Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 146 entries
Sorted by: Best Match Show Resources per page
Liabilities involved in conducting randomized clinical trials of CAM therapies in the absence of preliminary, foundational studies: a case in point.

Journal of alternative and complementary medicine (New York, N.Y.)

Margolin A.
PMID: 10100036
J Altern Complement Med. 1999 Feb;5(1):103-4. doi: 10.1089/acm.1999.5.103.

No abstract available.

Cite
Margolin A. Liabilities involved in conducting randomized clinical trials of CAM therapies in the absence of preliminary, foundational studies: a case in point. J Altern Complement Med. 1999;5(1):103-4doi: 10.1089/acm.1999.5.103.
Margolin, A. (1999). Liabilities involved in conducting randomized clinical trials of CAM therapies in the absence of preliminary, foundational studies: a case in point. Journal of alternative and complementary medicine (New York, N.Y.), 5(1), 103-4. https://doi.org/10.1089/acm.1999.5.103
Margolin, A. "Liabilities involved in conducting randomized clinical trials of CAM therapies in the absence of preliminary, foundational studies: a case in point." Journal of alternative and complementary medicine (New York, N.Y.) vol. 5,1 (1999): 103-4. doi: https://doi.org/10.1089/acm.1999.5.103
Margolin A. Liabilities involved in conducting randomized clinical trials of CAM therapies in the absence of preliminary, foundational studies: a case in point. J Altern Complement Med. 1999 Feb;5(1):103-4. doi: 10.1089/acm.1999.5.103. PMID: 10100036.
Copy Download .nbib Format: NLM
Reporting of power and sample size in randomized controlled trials.

JAMA

Burdick CO.
PMID: 7996641
JAMA. 1995 Jan 04;273(1):22.

No abstract available.

Cite
Burdick CO. Reporting of power and sample size in randomized controlled trials. JAMA. 1995;273(1):22
Burdick, C. O. (1995). Reporting of power and sample size in randomized controlled trials. JAMA, 273(1), 22.
Burdick, C O. "Reporting of power and sample size in randomized controlled trials." JAMA vol. 273,1 (1995): 22.
Burdick CO. Reporting of power and sample size in randomized controlled trials. JAMA. 1995 Jan 04;273(1):22. PMID: 7996641.
Copy Download .nbib Format: NLM
Ensuring completeness and transparency in the reporting of cases: the launch of the CARE guidelines.

Headache

Roberts J.
PMID: 24266332
Headache. 2013 Nov-Dec;53(10):1537-8. doi: 10.1111/head.12247.

No abstract available.

Cite
Roberts J. Ensuring completeness and transparency in the reporting of cases: the launch of the CARE guidelines. Headache. 2013;53(10):1537-8doi: 10.1111/head.12247.
Roberts, J. (2013). Ensuring completeness and transparency in the reporting of cases: the launch of the CARE guidelines. Headache, 53(10), 1537-8. https://doi.org/10.1111/head.12247
Roberts, Jason. "Ensuring completeness and transparency in the reporting of cases: the launch of the CARE guidelines." Headache vol. 53,10 (2013): 1537-8. doi: https://doi.org/10.1111/head.12247
Roberts J. Ensuring completeness and transparency in the reporting of cases: the launch of the CARE guidelines. Headache. 2013 Nov-Dec;53(10):1537-8. doi: 10.1111/head.12247. PMID: 24266332.
Copy Download .nbib Format: NLM
The Safewards study lacks rigour despite its randomised design.

International journal of nursing studies

Mustafa FA.
PMID: 26409299
Int J Nurs Stud. 2015 Dec;52(12):1906-7. doi: 10.1016/j.ijnurstu.2015.09.002. Epub 2015 Sep 15.

No abstract available.

Cite
Mustafa FA. The Safewards study lacks rigour despite its randomised design. Int J Nurs Stud. 2015;52(12):1906-7doi: 10.1016/j.ijnurstu.2015.09.002.
Mustafa, F. A. (2015). The Safewards study lacks rigour despite its randomised design. International journal of nursing studies, 52(12), 1906-7. https://doi.org/10.1016/j.ijnurstu.2015.09.002
Mustafa, Feras Ali. "The Safewards study lacks rigour despite its randomised design." International journal of nursing studies vol. 52,12 (2015): 1906-7. doi: https://doi.org/10.1016/j.ijnurstu.2015.09.002
Mustafa FA. The Safewards study lacks rigour despite its randomised design. Int J Nurs Stud. 2015 Dec;52(12):1906-7. doi: 10.1016/j.ijnurstu.2015.09.002. Epub 2015 Sep 15. PMID: 26409299.
Copy Download .nbib Format: NLM
A systematic review finds underreporting of ethics approval, informed consent, and incentives in clinical trials.

Journal of clinical epidemiology

Trung LQ, Morra ME, Truong ND, Turk T, Elshafie A, Foly A, Hien Tam DN, Iraqi A, Hong Van TT, Elgebaly A, Ngoc TN, Vu TLH, Chu NT, Hirayama K, Karbwang J, Huy NT.
PMID: 28866123
J Clin Epidemiol. 2017 Nov;91:80-86. doi: 10.1016/j.jclinepi.2017.08.007. Epub 2017 Sep 01.

OBJECTIVES: In this study, we aim to review researchers' reporting practices of the ethics statement, financial incentives, and local ethical committees' profile in their clinical trials.STUDY DESIGN AND SETTING: A systematic search was done through top-ranked 50 medical journals...

Cite
Trung LQ, Morra ME, Truong ND, et al. A systematic review finds underreporting of ethics approval, informed consent, and incentives in clinical trials. J Clin Epidemiol. 2017;91:80-86doi: 10.1016/j.jclinepi.2017.08.007.
Trung, L. Q., Morra, M. E., Truong, N. D., Turk, T., Elshafie, A., Foly, A., Hien Tam, D. N., Iraqi, A., Hong Van, T. T., Elgebaly, A., Ngoc, T. N., Vu, T. L. H., Chu, N. T., Hirayama, K., Karbwang, J., & Huy, N. T. (2017). A systematic review finds underreporting of ethics approval, informed consent, and incentives in clinical trials. Journal of clinical epidemiology, 9180-86. https://doi.org/10.1016/j.jclinepi.2017.08.007
Trung, Ly Quoc, et al. "A systematic review finds underreporting of ethics approval, informed consent, and incentives in clinical trials." Journal of clinical epidemiology vol. 91 (2017): 80-86. doi: https://doi.org/10.1016/j.jclinepi.2017.08.007
Trung LQ, Morra ME, Truong ND, Turk T, Elshafie A, Foly A, Hien Tam DN, Iraqi A, Hong Van TT, Elgebaly A, Ngoc TN, Vu TLH, Chu NT, Hirayama K, Karbwang J, Huy NT. A systematic review finds underreporting of ethics approval, informed consent, and incentives in clinical trials. J Clin Epidemiol. 2017 Nov;91:80-86. doi: 10.1016/j.jclinepi.2017.08.007. Epub 2017 Sep 01. PMID: 28866123.
Copy Download .nbib Format: NLM
Randomized clinical trials: in pursuit of higher standards.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Gunzburg R.
PMID: 25022860
Eur Spine J. 2014 Aug;23(8):1605. doi: 10.1007/s00586-014-3460-2. Epub 2014 Jul 15.

No abstract available.

Cite
Gunzburg R. Randomized clinical trials: in pursuit of higher standards. Eur Spine J. 2014;23(8):1605doi: 10.1007/s00586-014-3460-2.
Gunzburg, R. (2014). Randomized clinical trials: in pursuit of higher standards. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 23(8), 1605. https://doi.org/10.1007/s00586-014-3460-2
Gunzburg, Robert. "Randomized clinical trials: in pursuit of higher standards." European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society vol. 23,8 (2014): 1605. doi: https://doi.org/10.1007/s00586-014-3460-2
Gunzburg R. Randomized clinical trials: in pursuit of higher standards. Eur Spine J. 2014 Aug;23(8):1605. doi: 10.1007/s00586-014-3460-2. Epub 2014 Jul 15. PMID: 25022860.
Copy Download .nbib Format: NLM
Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge.

The Cochrane database of systematic reviews

Hróbjartsson A, Boutron I, Turner L, Altman DG, Moher D.
PMID: 23728703
Cochrane Database Syst Rev. 2013 Apr 30;(4):ED000058. doi: 10.1002/14651858.ED000058.

No abstract available.

Cite
Hróbjartsson A, Boutron I, Turner L, et al. Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge. Cochrane Database Syst Rev. 2013;(4):ED000058doi: 10.1002/14651858.ED000058.
Hróbjartsson, A., Boutron, I., Turner, L., Altman, D. G., Moher, D. (2013). Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge. The Cochrane database of systematic reviews, (4), ED000058. https://doi.org/10.1002/14651858.ED000058
Hróbjartsson, Asbjørn, et al. "Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge." The Cochrane database of systematic reviews vol. ,4 (2013): ED000058. doi: https://doi.org/10.1002/14651858.ED000058
Hróbjartsson A, Boutron I, Turner L, Altman DG, Moher D. Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge. Cochrane Database Syst Rev. 2013 Apr 30;(4):ED000058. doi: 10.1002/14651858.ED000058. PMID: 23728703.
Copy Download .nbib Format: NLM
On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development.

Pharmaceutical statistics

Carroll K, Hemmings R.
PMID: 26732132
Pharm Stat. 2016 Mar-Apr;15(2):135-42. doi: 10.1002/pst.1733. Epub 2016 Jan 06.

The rise over recent years in the use of network meta-analyses (NMAs) in clinical research and health economic analysis is little short of meteoric driven, in part, by a desire from decision makers to extend inferences beyond direct comparisons...

Cite
Carroll K, Hemmings R. On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development. Pharm Stat. 2016;15(2):135-42doi: 10.1002/pst.1733.
Carroll, K., & Hemmings, R. (2016). On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development. Pharmaceutical statistics, 15(2), 135-42. https://doi.org/10.1002/pst.1733
Carroll, Kevin, and Hemmings, Robert. "On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development." Pharmaceutical statistics vol. 15,2 (2016): 135-42. doi: https://doi.org/10.1002/pst.1733
Carroll K, Hemmings R. On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development. Pharm Stat. 2016 Mar-Apr;15(2):135-42. doi: 10.1002/pst.1733. Epub 2016 Jan 06. PMID: 26732132.
Copy Download .nbib Format: NLM
Impact evaluations of mental health programmes: the missing piece in global mental health.

Journal of epidemiology and community health

De Silva MJ.
PMID: 25492897
J Epidemiol Community Health. 2015 May;69(5):405-7. doi: 10.1136/jech-2014-203866. Epub 2014 Dec 09.

No abstract available.

Cite
De Silva MJ. Impact evaluations of mental health programmes: the missing piece in global mental health. J Epidemiol Community Health. 2014;69(5):405-7doi: 10.1136/jech-2014-203866.
De Silva, M. J. (2015). Impact evaluations of mental health programmes: the missing piece in global mental health. Journal of epidemiology and community health, 69(5), 405-7. https://doi.org/10.1136/jech-2014-203866
De Silva, Mary J. "Impact evaluations of mental health programmes: the missing piece in global mental health." Journal of epidemiology and community health vol. 69,5 (2015): 405-7. doi: https://doi.org/10.1136/jech-2014-203866
De Silva MJ. Impact evaluations of mental health programmes: the missing piece in global mental health. J Epidemiol Community Health. 2015 May;69(5):405-7. doi: 10.1136/jech-2014-203866. Epub 2014 Dec 09. PMID: 25492897.
Copy Download .nbib Format: NLM
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.

Systematic reviews

Savović J, Weeks L, Sterne JA, Turner L, Altman DG, Moher D, Higgins JP.
PMID: 24731537
Syst Rev. 2014 Apr 15;3:37. doi: 10.1186/2046-4053-3-37.

BACKGROUND: In 2008, the Cochrane Collaboration introduced a tool for assessing the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is based on narrative descriptions of evidence-based methodological features known to...

Cite
Savović J, Weeks L, Sterne JA, et al. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev. 2014;3:37doi: 10.1186/2046-4053-3-37.
Savović, J., Weeks, L., Sterne, J. A., Turner, L., Altman, D. G., Moher, D., & Higgins, J. P. (2014). Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Systematic reviews, 337. https://doi.org/10.1186/2046-4053-3-37
Savović, Jelena, et al. "Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation." Systematic reviews vol. 3 (2014): 37. doi: https://doi.org/10.1186/2046-4053-3-37
Savović J, Weeks L, Sterne JA, Turner L, Altman DG, Moher D, Higgins JP. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev. 2014 Apr 15;3:37. doi: 10.1186/2046-4053-3-37. PMID: 24731537; PMCID: PMC4022341.
Copy Download .nbib Format: NLM
[Risk of bias by blinded vs unblinded evaluation of articles in systematic reviews].

Ugeskrift for laeger

Møller AM.
PMID: 23582068
Ugeskr Laeger. 2013 Apr 01;175(14):951-4.

A Cochrane review investigated the effect of blinding information of authors, institutions, journals and sponsorships in assessing the presence of bias in trials that were assessed for inclusion in a systematic review. Six randomized trials were included. The results...

Cite
Møller AM. Risiko for bias ved blindet versus ublindet vurdering af artikler i systematiske oversigtsartikler--en gennemgang af et Cochranereview. [Risk of bias by blinded vs unblinded evaluation of articles in systematic reviews]. Ugeskr Laeger. 2013;175(14):951-4
Møller, A. M. (2013). Risiko for bias ved blindet versus ublindet vurdering af artikler i systematiske oversigtsartikler--en gennemgang af et Cochranereview. [Risk of bias by blinded vs unblinded evaluation of articles in systematic reviews]. Ugeskrift for laeger, 175(14), 951-4.
Møller, Ann Merete. "Risiko for bias ved blindet versus ublindet vurdering af artikler i systematiske oversigtsartikler--en gennemgang af et Cochranereview." [Risk of bias by blinded vs unblinded evaluation of articles in systematic reviews]. Ugeskrift for laeger vol. 175,14 (2013): 951-4.
Møller AM. Risiko for bias ved blindet versus ublindet vurdering af artikler i systematiske oversigtsartikler--en gennemgang af et Cochranereview. [Risk of bias by blinded vs unblinded evaluation of articles in systematic reviews]. Ugeskr Laeger. 2013 Apr 01;175(14):951-4. Danish. PMID: 23582068.
Copy Download .nbib Format: NLM
Assessing the quality of randomized controlled trials published in the Journal of Korean Medical Science from 1986 to 2011.

Journal of Korean medical science

Chung JH, Kang DH, Jo JK, Lee SW.
PMID: 22969240
J Korean Med Sci. 2012 Sep;27(9):973-80. doi: 10.3346/jkms.2012.27.9.973. Epub 2012 Aug 22.

Low quality clinical trials have a possibility to have errors in the process of deriving the results and therefore distort the study. Quality assessment of clinical trial is necessary in order to prevent any clinical application erroneous results is...

Cite
Chung JH, Kang DH, Jo JK, et al. Assessing the quality of randomized controlled trials published in the Journal of Korean Medical Science from 1986 to 2011. J Korean Med Sci. 2012;27(9):973-80doi: 10.3346/jkms.2012.27.9.973.
Chung, J. H., Kang, D. H., Jo, J. K., & Lee, S. W. (2012). Assessing the quality of randomized controlled trials published in the Journal of Korean Medical Science from 1986 to 2011. Journal of Korean medical science, 27(9), 973-80. https://doi.org/10.3346/jkms.2012.27.9.973
Chung, Jae Hoon, et al. "Assessing the quality of randomized controlled trials published in the Journal of Korean Medical Science from 1986 to 2011." Journal of Korean medical science vol. 27,9 (2012): 973-80. doi: https://doi.org/10.3346/jkms.2012.27.9.973
Chung JH, Kang DH, Jo JK, Lee SW. Assessing the quality of randomized controlled trials published in the Journal of Korean Medical Science from 1986 to 2011. J Korean Med Sci. 2012 Sep;27(9):973-80. doi: 10.3346/jkms.2012.27.9.973. Epub 2012 Aug 22. PMID: 22969240; PMCID: PMC3429837.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 146 entries